First Washington CORP lifted its holdings in shares of Intrexon Corporation (NYSE:XON) by 27.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,710 shares of the biotechnology company’s stock after purchasing an additional 42,180 shares during the period. Intrexon Corporation accounts for about 1.9% of First Washington CORP’s portfolio, making the stock its 23rd biggest position. First Washington CORP owned 0.16% of Intrexon Corporation worth $3,739,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in the stock. Synovus Financial Corp boosted its position in shares of Intrexon Corporation by 0.6% during the 2nd quarter. Synovus Financial Corp now owns 33,613 shares of the biotechnology company’s stock valued at $810,000 after purchasing an additional 200 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Intrexon Corporation by 0.6% during the 2nd quarter. Alliancebernstein L.P. now owns 32,610 shares of the biotechnology company’s stock valued at $786,000 after purchasing an additional 200 shares in the last quarter. Legal & General Group Plc boosted its position in shares of Intrexon Corporation by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 18,843 shares of the biotechnology company’s stock valued at $454,000 after purchasing an additional 393 shares in the last quarter. CWM LLC boosted its position in shares of Intrexon Corporation by 1.7% during the 2nd quarter. CWM LLC now owns 36,143 shares of the biotechnology company’s stock valued at $871,000 after purchasing an additional 597 shares in the last quarter. Finally, National Planning Corp boosted its position in shares of Intrexon Corporation by 13.4% during the 2nd quarter. National Planning Corp now owns 12,958 shares of the biotechnology company’s stock valued at $316,000 after purchasing an additional 1,528 shares in the last quarter. Institutional investors own 77.28% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2017/11/15/first-washington-corp-has-3-74-million-holdings-in-intrexon-corporation-xon.html.
XON has been the topic of several research analyst reports. BidaskClub lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a research report on Friday, August 4th. Northland Securities set a $30.00 target price on Intrexon Corporation and gave the company a “buy” rating in a research report on Monday, August 7th. JMP Securities restated an “outperform” rating and set a $42.00 target price on shares of Intrexon Corporation in a research report on Thursday, October 5th. Griffin Securities restated a “buy” rating and set a $55.00 target price on shares of Intrexon Corporation in a research report on Friday, October 6th. Finally, Zacks Investment Research lowered Intrexon Corporation from a “hold” rating to a “sell” rating in a research report on Monday, October 16th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $38.50.
Intrexon Corporation (NYSE:XON) traded up $0.10 during mid-day trading on Wednesday, reaching $12.68. The company had a trading volume of 2,820,700 shares, compared to its average volume of 1,118,467. Intrexon Corporation has a fifty-two week low of $10.26 and a fifty-two week high of $32.90. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 2.05.
In other news, Director Robert B. Shapiro purchased 2,850 shares of the company’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were acquired at an average cost of $17.50 per share, with a total value of $49,875.00. Following the purchase, the director now owns 43,157 shares in the company, valued at $755,247.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 56.30% of the stock is currently owned by corporate insiders.
Intrexon Corporation Company Profile
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).
Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.